Cell by Design
Master your ATMP development process
Advanced Therapy Medicinal Products (ATMPs) are a reality.
ATMPs are revolutionizing healthcare by introducing highly effective treatments for many different diseases and injuries.
However, manufacturing organizations have not been able to establish robust and cost-efficient processes for developing highly individualized drugs.
Cell by Design® (CbD) helps you overcome the major challenges currently faced by organizations developing and producing ATMPs.
Put quality first in your
process development roadmap
CbD enables you to opt for a quality-focused ATMP development process by executing risk-based process assessments.
Our insights guide science- and data-driven decisions to meet all pre-defined ATMP critical quality attributes.